Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369147 · ClinicalTrials.gov registry record · Phase 2

The Energy Dose Study

A Phase 2 study, sponsored by Emory University.

Terminated
Registry status
Phase 2
Development phase
12
Enrollment target

NCT01369147 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369147, a Phase 2 study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
Phase 2
Development phase
12 participants
Enrollment target

Study Summary

The investigators have designed this single-center Randomized Clinical Trial (RCT) to prospectively compare, for the first time, the clinical efficacy of different energy doses in intensive care unit (ICU) patients requiring parenteral nutrition (PN) due to intestinal failure/dysfunction. This study intends to enroll a total of 60 patients (20 per energy dose group) to generate critical preliminary data needed to inform subsequent appropriately powered Phase III multicenter trials.

Interventions

  • DRUG Propofol
  • DRUG Parenteral Nutrition
  • DRUG Clevidipine
  • DRUG Dextrose-containing IV Fluids
  • DRUG Enteral feeding

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2011-07
Est. Completion 2014-12-02
Phase Phase 2

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT01369147

The ClinicalTrials.gov registry entry for NCT01369147 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Propofol is the first listed.

NCT01369147 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01369147 about?

NCT01369147 is a clinical study titled "The Energy Dose Study". The investigators have designed this single-center Randomized Clinical Trial (RCT) to prospectively compare, for the first time, the clinical efficacy of different energy doses in intensive care unit (ICU) patients requiring parenteral nutrition (PN) due to intestinal failure/dysfunction. This study...

What is the current status of trial NCT01369147?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2011-07. Estimated completion is 2014-12-02.

What interventions are being tested in trial NCT01369147?

The interventions under investigation include: Propofol (DRUG), Parenteral Nutrition (DRUG), Clevidipine (DRUG), Dextrose-containing IV Fluids (DRUG), Enteral feeding (DRUG).

Who is sponsoring clinical trial NCT01369147?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.